Ziyuanyuan Holdings Group Limited (HKG:8223)
0.8300
+0.0400 (5.06%)
Jan 21, 2026, 4:08 PM HKT
Ziyuanyuan Holdings Group Revenue
Ziyuanyuan Holdings Group had revenue of 207.11M CNY in the half year ending June 30, 2025, with 24.52% growth. This brings the company's revenue in the last twelve months to 525.30M, up 6.60% year-over-year. In the year 2024, Ziyuanyuan Holdings Group had annual revenue of 498.71M with 4.21% growth.
Revenue (ttm)
525.30M CNY
Revenue Growth
+6.60%
P/S Ratio
0.59
Revenue / Employee
4.20M CNY
Employees
125
Market Cap
339.70M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 498.71M | 20.13M | 4.21% |
| Dec 31, 2023 | 478.57M | 173.20M | 56.72% |
| Dec 31, 2022 | 305.37M | 196.11M | 179.49% |
| Dec 31, 2021 | 109.26M | 60.48M | 123.97% |
| Dec 31, 2020 | 48.78M | -4.88M | -9.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |